Cytochrome P450 1B1 inhibition suppresses tumorigenicity of prostate cancer via caspase-1 activation.
Chang I, Mitsui Y, Kim SK, Sun JS, Jeon HS, Kang JY, Kang NJ, Fukuhara S, Gill A, Shahryari V, Tabatabai ZL, Greene KL, Dahiya R, Shin DM, Tanaka Y.
Chang I, et al.
Oncotarget. 2017 Jun 13;8(24):39087-39100. doi: 10.18632/oncotarget.16598.
Oncotarget. 2017.
PMID: 28388569
Free PMC article.